These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 684758

  • 1. Inhibition of mixed function oxidases in rat liver by trans- and cis-1,2-dichloroethylene.
    Freundt KJ, Macholz J.
    Toxicology; 1978 Jun; 10(2):131-9. PubMed ID: 684758
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of mono-oxygenase activities by 1,1,1-trichloropropene 2,3-oxide, an inhibitor of epoxide hydrase, in rat liver microsomes.
    Shimada T, Sato R.
    Biochem Pharmacol; 1979 Jun 01; 28(11):1777-81. PubMed ID: 475837
    [No Abstract] [Full Text] [Related]

  • 3. Mechanisms in the potentiation and inhibition of pharmacological actions of hexobarbital and zoxazolamine by glycofurol.
    Yasaka WJ, Sasame HA, Saul W, Maling HM, Gillette JR.
    Biochem Pharmacol; 1978 Jun 01; 27(24):2851-8. PubMed ID: 736977
    [No Abstract] [Full Text] [Related]

  • 4. Effect of hyperthyroidism on the in vitro metabolism and covalent binding of 1,1-dichloroethylene in rat liver microsomes.
    Gunasena GH, Kanz MF.
    J Toxicol Environ Health; 1997 Oct 10; 52(2):169-88. PubMed ID: 9310148
    [Abstract] [Full Text] [Related]

  • 5. Biphasic effect of methadone on hepatic drug metabolism.
    Komthong S, Yoovathaworn K, Thithapandha A.
    Proc Soc Exp Biol Med; 1987 Jan 10; 184(1):40-6. PubMed ID: 3797427
    [Abstract] [Full Text] [Related]

  • 6. Effects of furazolidone on duration of righting reflex loss induced with hexobarbital and zoxazolamine in the rat.
    Sasaki N.
    J Vet Med Sci; 1994 Aug 10; 56(4):667-70. PubMed ID: 7999888
    [Abstract] [Full Text] [Related]

  • 7. Effect of dibromotetrafluoroethane inhalation on hepatic drug metabolism in mice.
    Murphy JP, Van Stee EW, Back KC.
    Biochem Pharmacol; 1973 Nov 15; 22(22):2843-51. PubMed ID: 4761555
    [No Abstract] [Full Text] [Related]

  • 8. Effect of ozone on drug-induced sleeping time in mice pretreated with mixed-function oxidase inducers and inhibitors.
    Graham JA, Menzel DB, Miller FJ, Illing JW, Gardner DE.
    Toxicol Appl Pharmacol; 1982 Mar 15; 62(3):489-97. PubMed ID: 7071864
    [No Abstract] [Full Text] [Related]

  • 9. Cimetidine: a specific inhibitor of hepatic aryl hydrocarbon hydroxylase (AHH) in the rat.
    Drew R, Rowell J, Grygiel JJ.
    Res Commun Chem Pathol Pharmacol; 1981 Jul 15; 33(1):81-93. PubMed ID: 7268211
    [Abstract] [Full Text] [Related]

  • 10. Effect of hexachlorobenzene on hepatic microsomal enzymes in the rat.
    Stonard MD, Nenov PZ.
    Biochem Pharmacol; 1974 Aug 15; 23(15):2175-83. PubMed ID: 4413059
    [No Abstract] [Full Text] [Related]

  • 11. Hexobarbital sleeping time and drug metabolism in rats with ligated bile ducts--a lack of correlation.
    Drew R, Priestly BG.
    Biochem Pharmacol; 1976 Jul 15; 25(14):1659-63. PubMed ID: 942466
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of hepatic drug-metabolizing enzymes by arachidonic acid.
    Pessayre D, Mazel P, Descatoire V, Rogier E, Feldmann G, Benhamou JP.
    Xenobiotica; 1979 May 15; 9(5):301-10. PubMed ID: 115160
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of some rat hepatic microsomal enzymes by ethoxyquin.
    Parke DV, Rahim A, Walker R.
    Biochem Pharmacol; 1974 Dec 15; 23(24):3385-94. PubMed ID: 4374220
    [No Abstract] [Full Text] [Related]

  • 14. Protective effect of diethyldithiocarbamate and carbon disulfide against liver injury induced by various hepatotoxic agents.
    Masuda Y, Nakayama N.
    Biochem Pharmacol; 1982 Sep 01; 31(17):2713-25. PubMed ID: 6291543
    [Abstract] [Full Text] [Related]

  • 15. Effect of hexachlorophene, tribromsalan, trichlorcarban and cloflucarban on hexobarbital sleeping time and hepatic drug-metabolizing enzyme activity in vitro in the rat.
    Condie LW, Buhler DR.
    Biochem Pharmacol; 1979 Sep 01; 28(3):375-80. PubMed ID: 426854
    [No Abstract] [Full Text] [Related]

  • 16. Selectivity of cholestyramine treatment on hepatic mixed function oxidase activity.
    Bachmann K, Schwartz J, Forney R, Sherman G, Jauregui L.
    Pharmacology; 1984 Sep 01; 29(3):128-41. PubMed ID: 6483959
    [Abstract] [Full Text] [Related]

  • 17. Hepatotoxicity of vinyl chloride and 1,1-dichloroethylene. Role of mixed function oxidase system.
    Reynolds ES, Moslen MT, Szabo S, Jaeger RJ, Murphy SD.
    Am J Pathol; 1975 Oct 01; 81(1):219-36. PubMed ID: 241261
    [Abstract] [Full Text] [Related]

  • 18. Aminopyrine: metabolism and effects in the rat after administration of inhibitors of hepatic monooxygenases.
    Di Nucci A, Rugarli PL, Ferrini B, Tarozzi A, Gregotti C, Manzo L.
    Eur J Drug Metab Pharmacokinet; 1979 Oct 01; 4(3):179-83. PubMed ID: 118879
    [Abstract] [Full Text] [Related]

  • 19. Structure-activity relations for methylenedioxyphenyl and related compounds on hepatic microsomal enzyme function, as measured by prolongation of hexobarbital narcosis and zoxazolamine paralysis in mice.
    Fujii K, Jaffe H, Bishop Y, Arnold E, Mackintosh D, Epstein SS.
    Toxicol Appl Pharmacol; 1970 Mar 01; 16(2):482-94. PubMed ID: 5435617
    [No Abstract] [Full Text] [Related]

  • 20. Selective induction of renal microsomal cytochrome P-450-linked monooxygenases by 1,1-dichloroethylene in mice.
    Krijgsheld KR, Gram TE.
    Biochem Pharmacol; 1984 Jun 15; 33(12):1951-6. PubMed ID: 6610421
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.